Epidermal growth factor receptor inhibitors in oncology
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Cancer Research,Oncology
Reference47 articles.
1. ErbB3/HER3 intracellular domain is competent to bind ATP and catalyze autophosphorylation;Shi;Proc Natl Acad Sci U S A,2010
2. ErbB receptors and cancer: the complexity of targeted inhibitors;Hynes;Nat Rev Cancer,2005
3. Structural basis for inhibition of the epidermal growth factor receptor by cetuximab;Li;Cancer Cell,2005
4. Molecular predictors of response to epidermal growth factor receptor antagonists in nonsmall-cell lung cancer;Sequist;J Clin Oncol,2007
5. Screening for epidermal growth factor receptor mutations in lung cancer;Rosell;N Engl J Med,2009
Cited by 42 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Improved Production of Anti-FGF-2 Nanobody Using Pichia pastoris and Its Effect on Antiproliferation of Keratinocytes and Alleviation of Psoriasis;Archivum Immunologiae et Therapiae Experimentalis;2023-08-26
2. Developing four cuproptosis-related lncRNAs signature to predict prognosis and immune activity in ovarian cancer;Journal of Ovarian Research;2023-04-30
3. MicroRNA miR-100 Decreases Glioblastoma Growth by Targeting SMARCA5 and ErbB3 in Tumor-Initiating Cells;Technology in Cancer Research & Treatment;2020-01-01
4. MicroRNA miR-100 decreases glioblastoma growth by targeting SMARCA5 and ErbB3 in tumor-initiating cells;2019-12-04
5. Identification of Disease States and Response to Therapy in Humans by Utilizing the Biomarker EGFR for Targeted Molecular Imaging;Current Protein & Peptide Science;2016-07-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3